内镜下逆行胰胆管造影术后胰腺炎药物预防专家共识意见(2015年,上海)

中国医师协会胰腺病专业委员会; 中华医学会消化内镜学分会

doi:10.3969/j.issn.1001-5256.2016.05.002

内镜下逆行胰胆管造影术后胰腺炎药物预防专家共识意见(2015年,上海)

DOI: 10.3969/j.issn.1001-5256.2016.05.002

详细信息

中图分类号: R576
计量
- 文章访问数: 182
- HTML全文浏览量: 13
- PDF下载量: 484
- 被引次数: 0
出版历程
- 出版日期: 2016-05-20

Expert consensus on pharmacological prevention of pancreatitis after endoscopic retrograde cholangiopancreatography (2015, Shanghai)

摘要

摘要:
<正>内镜下逆行胰胆管造影术（endoscopic retrograde cholangiopancreatography,ERCP）是胰腺和胆道疾病的重要诊治手段,随着内镜技术的发展,ERCP的临床应用范围日趋广泛,已经成为胆胰疾病内镜微创诊治的标准方法。ERCP术后胰腺炎（post-ERCP pancreatitis,PEP）是ERCP最常见的并发症,发生率为5%左右,多为轻中度,少数为重度,严重时甚至可导致
- 胰腺炎 /
- 胰胆管造影术,内窥镜逆行 /
- 化学预防 /
- 共识
- pancreatitis /
- cholangiopancreatography,endoscopic retrograde /
- chemoprevention /
- consensus

HTML全文

参考文献(42)

[1]COTTON PB,LEHMAN G,VENNES J,et al.Endoscopic sphincterotomy complications and their management:an attempt at consensus[J].Gastrointest Endosc,1991,37(3):383-393.

[2] Professional Committee of Pancreatic Disease,Chinese Medical Doctor Association.Consensus statements on multidisciplinary diagnosis and treatment(MDT)of acute pancreatitis in China(draft)[J].Chin J Pancreatol,2015,15(4):217-224.(in Chinese)中国医师协会胰腺病学专业委员会.中国急性胰腺炎多学科(MDT)诊治共识意见(草案)[J].中华胰腺病杂志,2015,15(4):217-224.

[3] ERCP Section of Chinese Cociety of Digestive Endoscopy.Guidelines for the diagnostic and therapeutic ERCP[J].Chin J Dig Endosc,2010,27(3):113-118.(in Chinese)中华医学会消化内镜分会ERCP学组.ERCP诊治指南[J].中华消化内镜杂志,2010,27(3):113-118.

[4]ARATA S,TAKADA T,HIRATA K,et al.Post-ERCP pancreatitis[J].J Hepatobiliary Pancreat Sci,2010,17(1):70-78.

[5]WANG P,LI ZS,LIU F,et al.Risk factors for ERCP-related complications:a prospective multicenter study[J].Am J Gastroenterol,2009,104(1):31-40.

[6]LI ZS,XU GM,SUN ZX,et al.Early complications of diagnostic and therapeutic ERCP and its treatment[J].Chin J Dig Endosc,2002,19(2):77-80.(in Chinese)李兆申,许国铭,孙振兴,等.诊断性与治疗性ERCP早期并发症与处理[J].中华消化内镜杂志,2002,19(2):77-80.

[7]HU LH,LIAO Z,GAO R,et al.Comparison of complication and success rates of endoscopic retrograde cholangiopancreatography between 2001 and 2007:a retrospective report from Changhai hospital[J].Chin J Dig Endosc,2009,26(5):248-252.(in Chinese)胡良皞,廖专,高瑞,等.长海医院2001年与2007年ERCP成功率和并发症比较研究[J].中华消化内镜杂志,2009,26(5):248-252.

[8]ANDRIULLI A,LOPERFIDO S,NAPOLITANO G,et al.Incidence rates of post-ERCP complications:a systematic survey of prospective studies[J].Am J Gastroenterol,2007,102(8):1781-1788.

[9]WILLIAMS EJ,TAYLOR S,FAIRCLOUGH P,et al.Risk factors for complication following ERCP;results of a large-scale,prospective multicenter study[J].Endoscopy,2007,39(9):793-801.

[10]DUMONCEAU JM,ANDRIULLI A,ELMUNZER BJ,et al.Prophylaxis of post-ERCP pancreatitis:European Society of Gastrointestinal Endoscopy(ESGE)Guideline-updated June 2014[J].Endoscopy,2014,46(9):799-815.

[11]BAI Y,GAO F,GAO J,et al.Prophylactic antibiotics cannot prevent endoscopic retrograde cholangiopancreatography-induced cholangitis:a meta-analysis[J].Pancreas,2009,38(2):126-130.

[12]WONG LL,TSAI HH.Prevention of post-ERCP pancreatitis[J].World J Gastrointest Pathophysiol,2014,5(1):1-10.

[13]PUIG I,CALVET X,BAYLINA M,et al.How and when should NSAIDs be used for preventing post-ERCP pancreatitis?A systematic review and meta-analysis[J].PLoS One,2014,9(3):e92922.

[14]McD OWELL K,CLEMENTS JN.How can NSAIDs harm cardiovascular and renal function?[J].JAAPA,2014,27(4):12-15.

[15]RAI U,THRIMAWITHANA TR,VALERY C,et al.Therapeutic uses of somatostatin and its analogues:current view and potential applications[J].Pharmacol Ther,2015,152:98-110.

[16]BAI Y,REN X,ZHANG XF,et al.Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis:multicenter randomized controlled trial[J].Endoscopy,2015,47(5):415-420.

[17]STARITZ M,PORALLA T,EWE K,et al.Effect of glyceryl trinitrate on the sphincter of Oddi motility and baseline pressure[J].Gut,1985,26(2):194-197.

[18]BRANDSTTTER G,SCHINZEL S,WURZER H.Influence of spasmolytic analgesics on motility of sphincter of Oddi[J].Dig Dis Sci,1996,41(9):1814-1818.

[19]BAI Y,XU C,YANG X,et al.Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrogradecholangiopancreatography:a meta-analysis of randomized,double-blind,placebo-controlled trials[J].Endoscopy,2009,41(8):690-695.

[20]LI ZS,PAN X,ZHANG WJ,et al.Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia:a multicenter,placebo-controlled,randomized clinical trial[J].Am J Gastroenterol,2007,102(1):46-51.

[21]MANOLAKOPOULOS S,AVGERINOS A,VLACHOGIANNAKOS J,et al.Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis:a multicenter randomized controlled trial[J].Gastrointest Endosc,2002,55(4):470-475.

[22]BINMOELLER KF,HARRIS AG,DUMAS R,et al.Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?[J].Gut,1992,33(8):1129-1133.

[23]ZHANG YY,CHEN QB,GAO ZY,et al.Meta-analysis:octreotide prevents post-ERCP pancreatitis,but only at sufficient doses[J].Aliment Pharmacol Ther,2009,29(11):1155-1164.

[24]BAI Y,GAO J,ZOU DW,et al.Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis:a meta-analysis of randomized controlled trials[J].Pancreas,2008,37(3):241-246.

[25]YUHARA H,OGAWA M,KAWAGUCHI Y,et al.Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis:protease inhibitors and NSAIDs in a meta-analysis[J].J Gastroenterol,2014,49(3):388-399.

[26]ZHANG ZF,YANG N,ZHAO G,et al.Preventive effect of ulinastatin and gabexatemesylate on post-endoscopic retrograde cholangiopancreatography pancreatitis[J].Chin Med J(Engl),2010,123(18):2600-2606.

[27]MATSUSHITA M,TAKAKUWA H,SHIMENO N,et al.Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis[J].J Gastroenterol,2009,44(1):71-75.

[28]XU LH,QIAN JB,GU LG,et al.Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla[J].J Gastroenterol Hepatol,2011,26(7):1139-1144.

[29]BUXBAUM J,YAN A,YEH K,et al.Aggressive hydration with lactated Ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography[J].Clin Gastroenterol Hepatol,2014,12(2):303-307.

[30]SAGI SV,SCHMIDT S,FOGEL E,et al.Association of greater intravenous volume infusion with shorter hospitalization for patients with post-ERCP pancreatitis[J].J Gastroenterol Hepatol,2014,29(6):1316-1320.

[31]DIMAGNO MJ,WAMSTEKER EJ,MARATT J,et al.Do larger periprocedural fluid volumes reduce the severity of post-endoscopic retrograde cholangiopancreatography pancreatitis?[J].Pancreas,2014,43(4):642-647.

[32]BAI Y,GAO J,SHI X,et al.Prophylactic corticosteroids do not prevent post-ERCP pancreatitis:a meta-analysis of randomized controlled trials[J].Pancreatology,2008,8(4-5):504-509.

[33]DEVIRE J,le MOINE O,van LAETHEM JL,et al.Interleukin10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography[J].Gastroenterology,2001,120(2):498-505.

[34]SHERMANS S,CHENG CL,COSTAMAGNA G,et al.Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk[J].Pancreas,2009,38(3):267-274.

[35]LI S,CAO G,CHEN X,et al.Low-dose heparin in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis:a systematic review and meta-analysis[J].Eur J Gastroenterol Hepatol,2012,24(5):477-481.

[36]BAI Y,GAO J,ZHANG W,et al.Meta-analysis:allopurinol in the prevention of postendoscopic retrograde cholangiopancreatography pancreatitis[J].Aliment Pharmacol Ther,2008,28(5):557-564.

[37]KATSINELOS P,KOUNTOURAS J,PAROUTOGLOU G,et al.Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis[J].Gastrointest Endosc,2005,62(1):105-111.

[38]LAVY A,KARBAN A,SUISSA A,et al.Natural beta-carotene for the prevention of post-ERCP pancreatitis[J].Pancreas,2004,29(2):e45-e50.

[39]GORELICK A,BARNETT J,CHEY W,et al.Botulinum toxin injection after biliary sphincterotomy[J].Endoscopy,2004,36(2):170-173.

[40]SCHWARTZ JJ,LEW RJ,AHMAD NA,et al.The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis[J].Gastrointest Endosc,2004,59(2):179-184.

[41]PRAT F,AMARIS J,DUCOT B,et al.Nifedipine for prevention of post-ERCP pancreatitis:a prospective,double-blind randomized study[J].Gastrointest Endosc,2002,56(2):202-208.

[42]SAND J,NORDBACK I.Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography[J].Digestion,1993,54(2):105-111.

施引文献

资源附件(0)

访问统计